Details for: METOJECT SUBCUTANEOUS
Company: MEDEXUS INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02454831 | METOJECT SUBCUTANEOUS | METHOTREXATE (METHOTREXATE SODIUM) | 10 MG / 0.2 ML | SOLUTION | SUBCUTANEOUS |
| 02454750 | METOJECT SUBCUTANEOUS | METHOTREXATE (METHOTREXATE SODIUM) | 12.5 MG / 0.25 ML | SOLUTION | SUBCUTANEOUS |
| 02454858 | METOJECT SUBCUTANEOUS | METHOTREXATE (METHOTREXATE SODIUM) | 15 MG / 0.3 ML | SOLUTION | SUBCUTANEOUS |
| 02454769 | METOJECT SUBCUTANEOUS | METHOTREXATE (METHOTREXATE SODIUM) | 17.5 MG / 0.35 ML | SOLUTION | SUBCUTANEOUS |
| 02454866 | METOJECT SUBCUTANEOUS | METHOTREXATE (METHOTREXATE SODIUM) | 20 MG / 0.4 ML | SOLUTION | SUBCUTANEOUS |
| 02454777 | METOJECT SUBCUTANEOUS | METHOTREXATE (METHOTREXATE SODIUM) | 22.5 MG / 0.45 ML | SOLUTION | SUBCUTANEOUS |
| 02454874 | METOJECT SUBCUTANEOUS | METHOTREXATE (METHOTREXATE SODIUM) | 25 MG / 0.5 ML | SOLUTION | SUBCUTANEOUS |
Summary Reports
Regulatory Decision Summary
Summary Safety Review - Levetiracetam and Methotrexate - Assessing the Potential Risk of Drug-Drug Interaction
Summary Safety Review - Levetiracetam and Methotrexate - Assessing the Potential Risk of Drug-Drug Interaction
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.